Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
51.60
+0.40 (0.78%)
At close: Dec 5, 2025

Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 634.04 million as of December 5, 2025. Its market cap has increased by 31.59% in one year.

Market Cap
634.04M
Enterprise Value
602.46M
Revenue
236.21M
Ranking
n/a
PE Ratio
9.43
Stock Price
51.60

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 634.04M, an increase of 18.89%. That is a compound annual growth rate of 0.80%.

History

DateMarket Cap% Change
Dec 5, 2025634.04M26.50%
Dec 30, 2024501.21M18.52%
Dec 29, 2023422.90M-22.52%
Dec 30, 2022545.84M12.62%
Dec 30, 2021484.67M-15.59%
Dec 30, 2020574.19M14.12%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Roche Holding AG 266.08B
Novartis AG 205.46B
Galderma Group AG 38.65B
Lonza Group AG 38.51B
Alcon 32.12B
Sandoz Group AG 24.56B
Straumann Holding AG 14.62B
Sonova Holding AG 12.06B
Market Cap Rankings